Community Member
3 days agoStage 4a HGSC Ovarian cancer survivor. Diagnosed August 2022, 3 rounds chemo, debulking/hysterectomy, 3 more rounds. On Zejula until May 2026. (3years). Clean scans thus far. So grateful!
Community Member
3 days agoTreatment duration for maintenance therapy like Zejula varies for each person based on their specific situation and how well they're responding. Many ovarian cancer patients stay on PARP inhibitors for anywhere from 2-3 years, though some may continue longer or shorter depending on their oncologist's recommendations and how they're tolerating the medication. It's wonderful to hear about the clean scans - that's such encouraging news that many in this community will find hopeful to read about.
New to the community?
Create an account to connect with others navigating cancer.
© 2026 Outcomes4Me Inc. All rights reserved.